NCT05483517

Brief Summary

The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with rotator cuff tendinopathy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 2, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

January 31, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 8, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
6 months until next milestone

Results Posted

Study results publicly available

February 25, 2025

Completed
Last Updated

February 25, 2025

Status Verified

February 1, 2025

Enrollment Period

1.2 years

First QC Date

July 29, 2022

Results QC Date

November 19, 2024

Last Update Submit

February 21, 2025

Conditions

Keywords

rotator cuff tendinopathyhigh energy density pulse electromagnetic field

Outcome Measures

Primary Outcomes (1)

  • Change in Pain Visual Analogue Scale(VAS)

    The Visual Analog Scale (VAS) was used to measure pain intensity. The scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the worst possible pain. Higher scores indicate worse outcomes.

    baseline, immediate after treatment, 4 weeks, 12 weeks

Secondary Outcomes (4)

  • Change in Total Score of Shoulder Pain and Disability Index (SPADI)

    baseline, immediate after treatment, 4 weeks, 12 weeks

  • Changes of Shoulder Range of Motion in Active Flexion

    baseline, immediate after treatment, 4 weeks, 12 weeks

  • Changes of Shoulder Range of Motion in Active Abduction

    baseline, immediately after treatment, 4 weeks, 12 weeks

  • Changes of Shoulder Range of Motion in Active Internal Rotation

    baseline, immediately after treatment, 4 weeks, 12 weeks

Study Arms (2)

physiotherapy and high-PEMF

EXPERIMENTAL

The patient receives physiotherapy under the physiotherapist's guidance and high-PEMF therapy for three weeks, following two sessions a week.

Device: High energy density pulse electromagnetic fieldBehavioral: physiotherapy

physiotherapy and sham high-PEMF

SHAM COMPARATOR

The patient receives physiotherapy under the physiotherapist's guidance and sham high-PEMF therapy for three weeks, following two sessions a week.

Device: sham High energy density pulse electromagnetic fieldBehavioral: physiotherapy

Interventions

The treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. A normal energy of high-PEMF with a rate of 2 pulse per second is applied to the patient.

physiotherapy and high-PEMF

The sham treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. The setting is the same as the experimental group(normal energy, a rate of 2 pulse per second) with the difference that the energy output doesn't export to the patient.

physiotherapy and sham high-PEMF
physiotherapyBEHAVIORAL

Physiotherapy includes shoulder range of motion (ROM), stretching and muscle strengthening exercises. Under the physiotherapist's guidance, the patient receives the training session about 30 minutes every time.

physiotherapy and high-PEMFphysiotherapy and sham high-PEMF

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age between 20 to 75 years old
  • persistent shoulder pain for at least 3 months and pain VAS score \>=5
  • positive result in any of the following physical examinations: Hawkins-Kennedy, Neer or Jobe tests
  • confirmed rotator cuff tendinopathy by ultrasonography or MRI

You may not qualify if:

  • complete or full-thickness tear of rotator cuff found by ultrasonography or MRI
  • previous shoulder surgery
  • previous history of severe trauma in shoulder
  • cervical radiculopathy related shoulder pain or referred pain
  • other shoulder diseases: adhesive capsulitis, calcifying tendinopathy, radiology-confirmed acromion type III, shoulder instability, degenerative osteoarthritis, labral tear
  • present with any of the following systemic diseases: active infection, sever and uncontrolled medical condition, cancer, immune-related or rheumatoid arthritis, hyperuricemia and gout
  • previous treatment with articular or subacromial steroid injections within the last 3 months
  • cognitive impairment with loss of ability to sign the agreement and receive rehabilitation
  • pregnancy or lactating women
  • has any of the following contraindications: Carriers of pacemakers, internal defibrillators,internal metal implants (locally dependent), Cochlea implants, metallic stents, insulin pumps

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tri-service general hospital

Taipei, Neihu, 11490, Taiwan

Location

MeSH Terms

Conditions

Rotator Cuff Injuries

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Results Point of Contact

Title
Lai Chia-Ying
Organization
Tri-service general hospital

Study Officials

  • Liang cheng Chen, MD, MS

    Department of Physical Medicine and Rehabilitation, Tri-Service General

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

July 29, 2022

First Posted

August 2, 2022

Study Start

January 31, 2023

Primary Completion

April 8, 2024

Study Completion

August 30, 2024

Last Updated

February 25, 2025

Results First Posted

February 25, 2025

Record last verified: 2025-02

Locations